BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18302040)

  • 1. Interactive mixture as a rapid drug delivery system.
    Lee CC; Ong CL; Heng PW; Chan LW; Wong TW
    Drug Dev Ind Pharm; 2008 Feb; 34(2):206-14. PubMed ID: 18302040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
    Patil MP; Gaikwad NJ
    Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative dissolution studies for mefenamic acid-polyethylene glycol solid dispersion systems and tablets.
    Owusu-Ababio G; Ebube NK; Reams R; Habib M
    Pharm Dev Technol; 1998 Aug; 3(3):405-12. PubMed ID: 9742561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissolution rate of furosemide from polyethylene glycol solid dispersions.
    Ozdemir N; Ordu S
    Farmaco; 1997 Oct; 52(10):625-9. PubMed ID: 9507675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions.
    Karavas E; Georgarakis E; Sigalas MP; Avgoustakis K; Bikiaris D
    Eur J Pharm Biopharm; 2007 Jun; 66(3):334-47. PubMed ID: 17267194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of nano/micro-dispersions with improved dissolution properties upon dispersion of ritonavir melt extrudate in aqueous media.
    Tho I; Liepold B; Rosenberg J; Maegerlein M; Brandl M; Fricker G
    Eur J Pharm Sci; 2010 Apr; 40(1):25-32. PubMed ID: 20172027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of povidone K17 on the storage stability of solid dispersions of nimodipine and polyethylene glycol.
    Smikalla MM; Urbanetz NA
    Eur J Pharm Biopharm; 2007 Apr; 66(1):106-12. PubMed ID: 17055711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A; Cavallari C; Ospitali F
    Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and characterisation of interactive mixtures with a fine-particulate mucoadhesive carrier for nasal drug delivery.
    Fransén N; Björk E; Nyström C
    Eur J Pharm Biopharm; 2007 Sep; 67(2):370-6. PubMed ID: 17451925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solubility of selected derivatives of 1,4-benzodiazepin-2-one in solid dispersions in PEG 6000.
    Cwiertnia B
    Acta Pol Pharm; 2006; 63(2):135-9. PubMed ID: 17514877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of acidifiers in solid dispersions and physical mixtures.
    Tran TT; Tran PH; Choi HG; Han HK; Lee BJ
    Int J Pharm; 2010 Jan; 384(1-2):60-6. PubMed ID: 19782736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions.
    Verheyen S; Blaton N; Kinget R; Van den Mooter G
    Int J Pharm; 2002 Dec; 249(1-2):45-58. PubMed ID: 12433433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of microviscometry to study polymer dissolution from solid dispersion drug delivery systems.
    Esnaashari S; Javadzadeh Y; Batchelor HK; Conway BR
    Int J Pharm; 2005 Mar; 292(1-2):227-30. PubMed ID: 15725569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of nicotinamide, ethylurea and polyethylene glycol as carriers for nifedipine solid dispersion systems.
    Suzuki H; Sunada H
    Chem Pharm Bull (Tokyo); 1997 Oct; 45(10):1688-93. PubMed ID: 9353898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.
    Rumondor AC; Marsac PJ; Stanford LA; Taylor LS
    Mol Pharm; 2009; 6(5):1492-505. PubMed ID: 19634917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing dissolution, serum concentrations and hypoglycemic effect of glibenclamide using solvent deposition technique.
    Dastmalchi S; Garjani A; Maleki N; Sheikhee G; Baghchevan V; Jafari-Azad P; Valizadeh H; Barzegar-Jalali M
    J Pharm Pharm Sci; 2005 Aug; 8(2):175-81. PubMed ID: 16124928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relating solubility data of parabens in liquid PEG 400 to the behaviour of PEG 4000-parabens solid dispersions.
    Unga J; Tajarobi F; Norder O; Frenning G; Larsson A
    Eur J Pharm Biopharm; 2009 Oct; 73(2):260-8. PubMed ID: 19508891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissolution-modulating mechanism of alkalizers and polymers in a nanoemulsifying solid dispersion containing ionizable and poorly water-soluble drug.
    Tran TT; Tran PH; Lee BJ
    Eur J Pharm Biopharm; 2009 May; 72(1):83-90. PubMed ID: 19141319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of cryogenic grinding on properties of a self-emulsifying formulation.
    Chambin O; Jannin V; Champion D; Chevalier C; Rochat-Gonthier MH; Pourcelot Y
    Int J Pharm; 2004 Jun; 278(1):79-89. PubMed ID: 15158951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing an environmentally benign process for the production of microparticles: amphiphilic crystallization.
    Murnane D; Marriott C; Martin GP
    Eur J Pharm Biopharm; 2008 May; 69(1):72-82. PubMed ID: 18082385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.